ConductScience.org, home

Paper42864652PubMed

CRISPR integration of an FLT3 CAR into the TRAC locus generates CAR T cells for AML.

Noer MG and 12 others. Genome Med, 2026.

Cite this record

ConductScience Library. CRISPR integration of an FLT3 CAR into the TRAC locus generates CAR T cells for AML. Papers, record 42864652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42864652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CRISPR integration of an FLT3 CAR into the TRAC locus generates CAR T cells for AML.
Journal
Genome Med
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-15

Source PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Noer MGMaya G
2Christensen KBKimmie Bhttps://orcid.org/0000-0001-7255-3139
3Mikkelsen NSNanna S
4Skjelbostad SFSigrid Fu
5Rothemejer FHFrederik H
6Wittenborn TThomas
7Fammé SSimon
8Mikkelsen KKasper
9Barington TTorbenhttps://orcid.org/0000-0001-6968-148X
10Thomsen MKMartin K
11Barnkob MBMike Bhttps://orcid.org/0000-0002-5892-1174
12Møller BKBjarne K
13Bak RORasmus Ohttps://orcid.org/0000-0002-7383-0297

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
fms-Like Tyrosine Kinase 3Major topic
Leukemia, Myeloid, AcuteMajor topic
T-LymphocytesMajor topic
Immunotherapy, AdoptiveMajor topic
Receptors, Chimeric AntigenMajor topic
CRISPR-Cas SystemsMajor topic
Genetic LociMajor topic
Humans
Animals
Mice
Cell Line, Tumor

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
4-1612-391/1The Danish health authorities (SST)PubMed
101041231HORIZON EUROPE European Research CouncilPubMed
101057438Horizon 2020PubMed
R238-2016-3349Lundbeck FoundationPubMed
NNF19OC0058238Novo Nordisk FondenPubMed
8056-00010BInnovationsfondenPubMed
CF20-0424CarlsbergfondetPubMed

Source PubMed

Download CSV of grants

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119561539Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.J Immunother2009https://conductscience.org/library/papers/19561539PubMed
239833408Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.Nat Med2025https://conductscience.org/library/papers/39833408PubMed
337365642Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing.Mol Cancer2023https://conductscience.org/library/papers/37365642PubMed
440181544CAR-T cell therapy for treatment of acute myeloid leukemia, advances and outcomes.Mol Ther2025https://conductscience.org/library/papers/40181544PubMed
53252793341BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo.J Immunother Cancer2020https://conductscience.org/library/papers/32527933PubMed
635130342Molecular profile of FLT3-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinib.Blood Adv2022https://conductscience.org/library/papers/35130342PubMed
732241852Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing αβ T cell-depleted haploidentical hematopoietic stem cell transplantation.Haematologica2021https://conductscience.org/library/papers/32241852PubMed
828496177Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.Leukemia2017https://conductscience.org/library/papers/28496177PubMed
937794590Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells.Cell2023https://conductscience.org/library/papers/37794590PubMed
1029716633Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells.J Hematol Oncol2018https://conductscience.org/library/papers/29716633PubMed
1132518207Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia.Mol Cancer Ther2020https://conductscience.org/library/papers/32518207PubMed
1239946666Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies.J Clin Oncol2025https://conductscience.org/library/papers/39946666PubMed
1331088841Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.Cancer Discov2019https://conductscience.org/library/papers/31088841PubMed
1428956530Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6.Elife2017https://conductscience.org/library/papers/28956530PubMed
1539300079Current status and research directions in acute myeloid leukemia.Blood Cancer J2024https://conductscience.org/library/papers/39300079PubMed
1638583184CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma.Cancer Discov2024https://conductscience.org/library/papers/38583184PubMed
1740367950Emerging trends in clinical allogeneic CAR cell therapy.Med2025https://conductscience.org/library/papers/40367950PubMed
1839013470Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis.Cell2024https://conductscience.org/library/papers/39013470PubMed
1937330575Biomarkers as targets for CAR-T/NK cell therapy in AML.Biomark Res2023https://conductscience.org/library/papers/37330575PubMed
2032014868Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges.Cancer Discov2020https://conductscience.org/library/papers/32014868PubMed

See all 67 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42864652

GET https://conductscience.org/api/papers/v1/42864652/references?page=2